NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

5761. Oncology therapeutic radiopharmaceuticals: nonclinical studies and labeling recommendations

5763. Osteoporosis: nonclinical evaluation of drugs intended for treatment

5764. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products

5765. Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications: guidance for industry and Food and Drug Administration staff

5766. Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff

5767. Evaluation of internal standard responses during chromatographic bioanalysis: questions and answers

5768. Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older

5769. Humanitarian device exemption (HDE) program: guidance for industry and Food and Drug Administration staff